T Lymphocyte-mediated Protection Against Pseudomonas Aeruginosa Infection in Granulocytopenic Mice

Overview

Journal J Clin Invest

Specialty General Medicine

Date 1986 Aug 1

PMID 2426306

Citations 12

Authors

W G Powderly

G B Pier

R B Markham

Affiliations

Soon will be listed here.

Abstract

BALB/c mice immunized with Pseudomonas aeruginosa immunotype 1 polysaccharide develop protective T cell immunity to bacterial challenge. In vitro, T cells from immunized mice kill P. aeruginosa by production of a bactericidal lymphokine. The present study demonstrates that adoptive transfer of T cells from immunized BALB/c mice to granulocytopenic mice resulted in 97% survival on challenge with P. aeruginosa, compared with 17% survival with adoptive transfer of T cells from nonimmune BALB/c mice. This protection is specifically elicited by reexposure to the original immunizing antigen; adoptive recipients cannot withstand challenge with immunotype 3 P. aeruginosa. However, the adoptive recipients do survive simultaneous infection with both P. aeruginosa immunotypes 1 and 3. Adoptive transfer of T cells from the congenic CB.20 mice, which are unable to kill P. aeruginosa in vitro, provides only 20% protection to granulocytopenic mice. These studies indicate that transfer of specific immune T lymphocytes can significantly enhance the resistance to P. aeruginosa infection in granulocytopenic mice.

Citing Articles

Gearing up for battle: Harnessing adaptive T cell immunity against gram-negative pneumonia.

Gao C, Morales-Nebreda L, Pickens C Front Cell Infect Microbiol. 2022; 12:934671.

PMID: 36061870 PMC: 9433749. DOI: 10.3389/fcimb.2022.934671.

CXCL4 contributes to host defense against acute Pseudomonas aeruginosa lung infection.

Yue L, Pang Z, Li H, Yang T, Guo L, Liu L PLoS One. 2018; 13(10):e0205521.

PMID: 30296305 PMC: 6175521. DOI: 10.1371/journal.pone.0205521.

Improved outcome of chronic Pseudomonas aeruginosa lung infection is associated with induction of a Th1-dominated cytokine response.

Moser C, Jensen P, Kobayashi O, Hougen H, Song Z, Rygaard J Clin Exp Immunol. 2002; 127(2):206-13.

PMID: 11876741 PMC: 1906339. DOI: 10.1046/j.1365-2249.2002.01731.x.

Characterization of T cell clones derived from lymph nodes and lungs of Pseudomonas aeruginosa-susceptible and resistant mice following immunization with heat-killed bacteria.

Kondratieva T, Kobets N, Khaidukov S, Yeremeev V, Lyadova I, Apt A Clin Exp Immunol. 2000; 121(2):275-82.

PMID: 10931142 PMC: 1905701. DOI: 10.1046/j.1365-2249.2000.01222.x.

Direct activity of human T lymphocytes and natural killer cells against Cryptococcus neoformans.

Levitz S, Dupont M, Smail E Infect Immun. 1994; 62(1):194-202.

PMID: 8262627 PMC: 186086. DOI: 10.1128/iai.62.1.194-202.1994.

References

Schimpff S, YOUNG V, Greene W, Vermeulen G, Moody M, Wiernik P . Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens. Ann Intern Med. 1972; 77(5):707-14. DOI: 10.7326/0003-4819-77-5-707. View

Young L . Symposium on infectious complications of neoplastic disease (Part II). Immunoprophylaxis and serotherapy of bacterial infections. Am J Med. 1984; 76(4):664-71. DOI: 10.1016/0002-9343(84)90292-4. View

Pier G, Markham R, Eardley D . Correlation of the biologic responses of C3H/HEJ mice to endotoxin with the chemical and structural properties of the lipopolysaccharides from Pseudomonas aeruginosa and Escherichia coli. J Immunol. 1981; 127(1):184-91. View

Markham R, Pier G, Goellner J, Mizel S . In vitro T cell-mediated killing of Pseudomonas aeruginosa. II. The role of macrophages and T cell subsets in T cell killing. J Immunol. 1985; 134(6):4112-7. View

Shapiro M, Onderdonk A, Kasper D, Finberg R . Cellular immunity to Bacteroides fragilis capsular polysaccharide. J Exp Med. 1982; 155(4):1188-97. PMC: 2186655. DOI: 10.1084/jem.155.4.1188. View

Stossel T . Phagocytosis: recognition and ingestion. Semin Hematol. 1975; 12(1):83-116. View

Winston D, Ho W, Gale R . Therapeutic granulocyte transfusions for documented infections. A controlled trial in ninety-five infectious granulocytopenic episodes. Ann Intern Med. 1982; 97(4):509-15. DOI: 10.7326/0003-4819-97-4-509. View

Young L, Martin W, Meyer R, Weinstein R, Anderson E . Gram-negative rod bacteremia: microbiologic, immunologic, and therapeutic considerations. Ann Intern Med. 1977; 86(4):456-71. DOI: 10.7326/0003-4819-86-4-456. View

Powderly W, Pier G, Markham R . In vitro T cell-mediated killing of Pseudomonas aeruginosa. III. The role of suppressor T cells in nonresponder mice. J Immunol. 1986; 136(1):299-303. View

10.

Bodey G, Buckley M, SATHE Y, Freireich E . Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med. 1966; 64(2):328-40. DOI: 10.7326/0003-4819-64-2-328. View

11.

Lukacher A, Braciale V, Braciale T . In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific. J Exp Med. 1984; 160(3):814-26. PMC: 2187390. DOI: 10.1084/jem.160.3.814. View

12.

Schimpff S, Greene W, YOUNG V, Wiernik P . Significance of Pseudomonas aeruginosa in the patient with leukemia or lymphoma. J Infect Dis. 1974; 130 Suppl(0):S24-31. DOI: 10.1093/infdis/130.supplement.s24. View

13.

Onderdonk A, Markham R, Zaleznik D, Cisneros R, Kasper D . Evidence for T cell-dependent immunity to Bacteroides fragilis in an intraabdominal abscess model. J Clin Invest. 1982; 69(1):9-16. PMC: 371162. DOI: 10.1172/jci110445. View

14.

Pier G, Markham R . Induction in mice of cell-mediated immunity to Pseudomonas aeruginosa by high molecular weight polysaccharide and vinblastine. J Immunol. 1982; 128(5):2121-5. View

15.

Markham R, Pier G . Characterization of the antibody response in inbred mice to a high-molecular-weight polysaccharide from Pseudomonas aeruginosa immunotype 1. Infect Immun. 1983; 41(1):232-6. PMC: 264768. DOI: 10.1128/iai.41.1.232-236.1983. View

16.

Mantel N, Haenszel W . Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959; 22(4):719-48. View

17.

Pier G . Safety and immunogenicity of high molecular weight polysaccharide vaccine from immunotype 1 Pseudomonas aeruginosa. J Clin Invest. 1982; 69(2):303-8. PMC: 370979. DOI: 10.1172/jci110453. View

18.

Wysocki L, Sato V . "Panning" for lymphocytes: a method for cell selection. Proc Natl Acad Sci U S A. 1978; 75(6):2844-8. PMC: 392661. DOI: 10.1073/pnas.75.6.2844. View

19.

Markham R, Goellner J, Pier G . In vitro T cell-mediated killing of Pseudomonas aeruginosa. I. Evidence that a lymphokine mediates killing. J Immunol. 1984; 133(2):962-8. View

20.

Cryz Jr S, Furer E, Germanier R . Simple model for the study of Pseudomonas aeruginosa infections in leukopenic mice. Infect Immun. 1983; 39(3):1067-71. PMC: 348064. DOI: 10.1128/iai.39.3.1067-1071.1983. View